170849 ⎘
Detection or diagnosis of diseases; Neurological disorders Cerebrovascular disorders, e.g. stroke, cerebral infarct, cerebral haemorrhage, transient ischemic event
Method for treatment of cardiovascular and metabolic diseases and detecting the risk of the same
#302Devices and methods for enrichment and alteration of circulating tumor cells and other particles
#303Cellular fibronectin as a diagnostic marker in stroke and methods of use thereof
#304Methods for diagnosing and treating cerebrovascular events based on NR2 peptides
#305Ischemic biomarkers and their use to predict adverse neurological events from surgery
#306Use of GFAP for identification of intracerebral hemorrhage
#307IL1RL-1 as a cardiovascular disease marker and therapeutic target
#308Internally administered therapeutic agents for cranial nerve diseases comprising mesenchymal cells as an active ingredient
#309Antibody assay methods to assess risk for TIA/stroke
#310Assay methods for immediate diagnosis of cause of stroke
#311Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level
#312Glutamate transport modulatory compounds and methods
#313CaMKII/calcium channel binding-related compositions and methods
#314Methods for detecting Xanthrochromia
#315Biological markers for longevity and diseases and uses thereof
#316Rapid multiple panel of biomarkers in laboratory blood tests for TIA/stroke
#317Diagnostic markers of stroke and cerebral injury and methods of use thereof
#318Multiparameter method of screening for atherosclerosis-related coronary heart disease or stroke
#319Diagnostic markers of cardiovascular illness and methods of use thereof
#320Neuroglobin is up-regulated by and protects neurons from hypoxic-ischemic injury
#321Diagnostic method for stroke
#322Method for diagnosing and distinguishing stroke and diagnostic devices for use therein
#323Cellular fibronectin as a diagnostic marker in stroke and methods of use thereof
#324Methods for diagnosis of cardiovascular disease
#325Amyloid beta-peptide and methods of use
#326Method and system for optically performing an assay to determine a medical condition
#327Methods of reducing vascular permeability in tissue by inhibition of tissue plasminogen activator (tPA) and tPA inhibitors useful therein
#328Blood biomarker for early blood brain barrier disruption in ischemic stroke
#329Methods and systems for prognosis and diagnosis of brain damage